Stay updated on Dupilumab in ABPA Treatment Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section updated to say publications are automatically filled from PubMed and may not be about the study, with the revision labeled v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedDeletion of the government funding notice from the study page. The notice previously warned that information may not be up to date and directed users to NIH and OPM status pages.SummaryDifference0.3%

- Check42 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page (NCT04442269); the content and layout appear the same.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedAdds Revision: v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and Revision: v3.0.2; overall, updates versioning and trims older topics.SummaryDifference0.4%

- Check92 days agoChange DetectedPage revision updated to v3.0.2 and 'Back to Top' link removed.SummaryDifference0.2%

Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.